Belite Bio, Inc. (BLTE)
178.30
-4.86
(-2.65%)
USD |
NASDAQ |
Sep 10, 11:46
Belite Bio Price to Book Value : 9.246 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 09, 2026 | 9.498 |
| September 08, 2026 | 10.00 |
| September 04, 2026 | 10.04 |
| September 03, 2026 | 8.872 |
| September 02, 2026 | 8.331 |
| September 01, 2026 | 8.126 |
| August 31, 2026 | 8.074 |
| August 28, 2026 | 7.867 |
| August 27, 2026 | 8.142 |
| August 26, 2026 | 8.125 |
| August 25, 2026 | 8.384 |
| August 24, 2026 | 8.238 |
| August 21, 2026 | 8.352 |
| August 20, 2026 | 8.397 |
| August 19, 2026 | 8.740 |
| August 18, 2026 | 8.43 |
| August 17, 2026 | 8.463 |
| August 14, 2026 | 8.442 |
| August 13, 2026 | 8.622 |
| August 12, 2026 | 9.279 |
| August 11, 2026 | 9.208 |
| August 10, 2026 | 8.673 |
| August 07, 2026 | 8.455 |
| August 06, 2026 | 8.332 |
| August 05, 2026 | 8.219 |
| Date | Value |
|---|---|
| August 04, 2026 | 8.155 |
| August 03, 2026 | 8.027 |
| July 31, 2026 | 8.225 |
| July 30, 2026 | 8.293 |
| July 29, 2026 | 7.905 |
| July 28, 2026 | 8.087 |
| July 27, 2026 | 8.215 |
| July 24, 2026 | 7.952 |
| July 23, 2026 | 8.104 |
| July 22, 2026 | 8.148 |
| July 21, 2026 | 8.353 |
| July 20, 2026 | 7.925 |
| July 17, 2026 | 7.782 |
| July 16, 2026 | 7.813 |
| July 15, 2026 | 7.751 |
| July 14, 2026 | 7.606 |
| July 13, 2026 | 7.624 |
| July 10, 2026 | 7.743 |
| July 09, 2026 | 7.946 |
| July 08, 2026 | 7.897 |
| July 07, 2026 | 8.177 |
| July 06, 2026 | 7.987 |
| July 02, 2026 | 7.603 |
| July 01, 2026 | 7.379 |
| June 30, 2026 | 7.985 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.6135 |
| CorMedix, Inc. | 1.348 |
| Eloxx Pharmaceuticals, Inc. | 1.435 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 4.732 |
Price to Book Value Related Metrics
| PEG Ratio | -0.8525 |
| Price | 178.30 |
| Earnings Yield | -1.53% |
| Market Cap | 7.181B |
| PEGY Ratio | -0.8525 |